Andrew Jea to Recombinant Proteins
This is a "connection" page, showing publications Andrew Jea has written about Recombinant Proteins.
Connection Strength
0.993
-
Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine: safety profile and efficacy in the early postoperative period. Neurosurgery. 2010 Nov; 67(5):1195-204; discussion 1204.
Score: 0.332
-
Survey of the Effectiveness of Internet Information on Patient Education for Bone Morphogenetic Protein. World Neurosurg. 2016 Mar; 87:613-8.
Score: 0.117
-
The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography. J Neurosurg Pediatr. 2015 Jul; 16(1):14-20.
Score: 0.113
-
Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer. J Neurosurg Pediatr. 2015 Jul; 16(1):4-13.
Score: 0.113
-
The feasibility and safety of using sublaminar polyester bands in hybrid spinal constructs in children and transitional adults for neuromuscular scoliosis. J Neurosurg Pediatr. 2015 Mar; 15(3):328-37.
Score: 0.111
-
Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors. J Neurosurg Pediatr. 2014 Nov; 14(5):476-85.
Score: 0.108
-
Rh-BMP-2 for L5-S1 arthrodesis in long fusions to the pelvis for neuromuscular spinal deformity in the pediatric age group: analysis of 11 patients. Childs Nerv Syst. 2014 Feb; 30(2):249-55.
Score: 0.100